Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Dan Peisert Stepping Down as CEO
Board member Heather Mason Appointed Interim CEO
LAKE FOREST, Ill., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (NASDAQ:ASRT), a specialty pharmaceutical company that acquires, commercializes and develops safe and effective therapies that make a difference in the lives of patients, announced today that Dan Peisert is stepping down as the Company's Chief Executive Officer. The Board has appointed Heather Mason, currently an independent director of the Company and Chair of its Nominating and Corporate Governance Committee, to serve as interim CEO as the Company conducts a search for a permanent chief executive.
Peter Staple, Chairman of the Assertio Board of Directors, said, "On behalf of the Board, I would like to express our appreciation to Dan for his contributions to the growth and transformation of Assertio in his roles as CEO, and earlier as CFO."
Ms. Mason has served as a member of the Assertio board since 2019 and brings deep experience as a leader in the pharmaceutical and healthcare industry with a strong track record in successful commercial execution. She has held several senior leadership positions at Abbott Laboratories, including Executive Vice President, Nutrition, Senior Vice President of Diabetes Care, Vice President of Specialty Pharmaceuticals and Vice President, International Marketing, and played a key role in Abbott's launch and commercialization of Humira®, one of the most successful pharmaceutical products in history.
"I am committed to Assertio and its employees and stakeholders, and its future success," Ms. Mason said. "I will work to ensure that we are best positioned to maximize the opportunities in front of us, and to ensure a smooth leadership transition as we bring in a CEO to lead the Company into the next phase of our business."
Posted In: ASRT